Diagnosing and Treating the Elderly Individual with Hypopituitarism

Overview

Journal Rev Endocr Metab Disord

Publisher Springer

Specialty Endocrinology

Date 2023 Dec 27

PMID 38150092

Authors

Andrea Corsello

Rosa Maria Paragliola

Roberto Salvatori

Affiliations

Soon will be listed here.

Abstract

Hypopituitarism in the elderly is an underestimated condition mainly due to the non-specific presentation that can be attributed to the effects of aging and the presence of comorbidities. Diagnosis and treatment of hypopituitarism often represent a challenging task and this is even more significant in the elderly. Diagnosis can be insidious due to the physiological changes occurring with aging that complicate the interpretation of hormonal investigations, and the need to avoid some provocative tests that carry higher risks of side effects in this population. Treatment of hypopituitarism has generally the goal to replace the hormonal deficiencies to restore a physiological balance as close as possible to that of healthy individuals but in the elderly this must be balanced with the risks of over-replacement and worsening of comorbidities. Moreover, the benefit of some hormonal replacement therapies in the elderly, including sex hormones and growth hormone, remains controversial.

Citing Articles

Update on regulation of GHRH and its actions on GH secretion in health and disease.

Montero-Hidalgo A, Del Rio-Moreno M, Perez-Gomez J, Luque R, Kineman R Rev Endocr Metab Disord. 2025; .

PMID: 39838154 DOI: 10.1007/s11154-025-09943-y.

References

Regal M, Paramo C, Sierra S, Garcia-Mayor R . Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2002; 55(6):735-40. DOI: 10.1046/j.1365-2265.2001.01406.x. View

Pappachan J, Raskauskiene D, Raman Kutty V, Clayton R . Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies. J Clin Endocrinol Metab. 2015; 100(4):1405-11. DOI: 10.1210/jc.2014-3787. View

Singh S, Bajorek B . Defining 'elderly' in clinical practice guidelines for pharmacotherapy. Pharm Pract (Granada). 2015; 12(4):489. PMC: 4282767. DOI: 10.4321/s1886-36552014000400007. View

Tanriverdi F, Dokmetas H, Kebapci N, Kilicli F, Atmaca H, Yarman S . Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from Pituitary Study Group database. Endocrine. 2013; 47(1):198-205. DOI: 10.1007/s12020-013-0127-4. View

Karaca Z, Laway B, Dokmetas H, Atmaca H, Kelestimur F . Sheehan syndrome. Nat Rev Dis Primers. 2016; 2:16092. DOI: 10.1038/nrdp.2016.92. View

Villar-Taibo R, Diaz-Ortega C, Sifontes-Dubon M, Fernandez-Pombo A, Serramito-Garcia R, Martinez-Capoccioni G . Pituitary surgery in elderly patients: a safe and effective procedure. Endocrine. 2021; 72(3):814-822. DOI: 10.1007/s12020-021-02665-6. View

Nomikos P, Ladar C, Fahlbusch R, Buchfelder M . Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients. Acta Neurochir (Wien). 2004; 146(1):27-35. DOI: 10.1007/s00701-003-0174-3. View

Jahangiri A, Wagner J, Han S, Tran M, Miller L, Chen R . Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis. J Neurosurg. 2015; 124(3):589-95. DOI: 10.3171/2015.1.JNS141543. View

Cohen-Inbar O, Ramesh A, Xu Z, Vance M, Schlesinger D, Sheehan J . Gamma knife radiosurgery in patients with persistent acromegaly or Cushing's disease: long-term risk of hypopituitarism. Clin Endocrinol (Oxf). 2015; 84(4):524-31. DOI: 10.1111/cen.12938. View

10.

Klose M, Juul A, Struck J, Morgenthaler N, Kosteljanetz M, Feldt-Rasmussen U . Acute and long-term pituitary insufficiency in traumatic brain injury: a prospective single-centre study. Clin Endocrinol (Oxf). 2007; 67(4):598-606. DOI: 10.1111/j.1365-2265.2007.02931.x. View

11.

Schneider H, Schneider M, Saller B, Petersenn S, Uhr M, Husemann B . Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol. 2006; 154(2):259-65. DOI: 10.1530/eje.1.02071. View

12.

Schneider H, Kreitschmann-Andermahr I, Ghigo E, Stalla G, Agha A . Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA. 2007; 298(12):1429-38. DOI: 10.1001/jama.298.12.1429. View

13.

Bondanelli M, Ambrosio M, Carli A, Bergonzoni A, Bertocchi A, Zatelli M . Predictors of pituitary dysfunction in patients surviving ischemic stroke. J Clin Endocrinol Metab. 2010; 95(10):4660-8. DOI: 10.1210/jc.2010-0611. View

14.

Tanriverdi F, Schneider H, Aimaretti G, Masel B, Casanueva F, Kelestimur F . Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach. Endocr Rev. 2015; 36(3):305-42. DOI: 10.1210/er.2014-1065. View

15.

Torino F, Corsello S, Salvatori R . Endocrinological side-effects of immune checkpoint inhibitors. Curr Opin Oncol. 2016; 28(4):278-87. DOI: 10.1097/CCO.0000000000000293. View

16.

Caturegli P, Di Dalmazi G, Lombardi M, Grosso F, Larman H, Larman T . Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series. Am J Pathol. 2016; 186(12):3225-3235. PMC: 5225294. DOI: 10.1016/j.ajpath.2016.08.020. View

17.

Barnabei A, Strigari L, Corsello A, Paragliola R, Falzone L, Salvatori R . Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?. Front Oncol. 2022; 12:798517. PMC: 8927719. DOI: 10.3389/fonc.2022.798517. View

18.

Biondi B . The normal TSH reference range: what has changed in the last decade?. J Clin Endocrinol Metab. 2013; 98(9):3584-7. DOI: 10.1210/jc.2013-2760. View

19.

Hollowell J, Staehling N, Flanders W, Hannon W, Gunter E, Spencer C . Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87(2):489-99. DOI: 10.1210/jcem.87.2.8182. View

20.

Kahapola-Arachchige K, Hadlow N, Wardrop R, Lim E, Walsh J . Age-specific TSH reference ranges have minimal impact on the diagnosis of thyroid dysfunction. Clin Endocrinol (Oxf). 2012; 77(5):773-9. DOI: 10.1111/j.1365-2265.2012.04463.x. View